Selected News
New weapons against cancer: millions of bacteria programmed to kill The New York Times
Bacteria deliver the goods
Nature Reviews Drug Discovery
Hacking bacteria to fight cancer
TED-Ed
Reimagining cancer research with art
Nature Reviews Cancer
News
2024
Highlight in AACR: From The Bench: Jonathan Pabón, PhD
Highlight in CDMRP: Programmable Probiotics for Targeted Breast Cancer Therapy
Our work on engineering probiotics to detect and treat colorectal cancer in Nature Communications!
See paper here: Colorectal cancer detection and treatment with engineered probiotics
Beautiful Bacteria -> a book curating our lab's bacterial art is now out
News highlights:Columbia News: Finding Beauty in the World of Microbes
New York Times: Glorious Germs, Ready for Their Close-Up
2023
Our review on bacterial therapies at the interface of synthetic biology and nanomedicine in Nature Reviews Bioengineering!
See our paper here: Bacterial therapies at the interface of synthetic biology and nanomedicine
Our work on engineering tumor homing probiotics to improve CAR-T cell targeting of solid tumors is out now in Science!
See paper here: Probiotic-guided CAR-T cells for solid tumor targetingPress releases:
• Nature Reviews Drug Discovery: Bacteria tag tumours for CAR-T cell attack
• Nature Biotechnology Research Highlights: A bacterial assist for CAR-T cells
• ScienceAdviser: Engineered bacteria + CAR-T cells: A dynamic duo to crush cancer?
• Science Perspectives: Engineered bacteria guide T cells to tumors
• Columbia News: Engineered Bacteria Paint Targets on Tumors for Cancer-killing T Cells to See
Zak Singer and Jonathan Pabon’s preprint is online! Engineered bacteria launch and control an oncolytic virus
Nature Reviews Bioengineering: Bacterial therapies at the interface of synthetic biology and nanomedicine
Our work on engineering bacterial patterns as visible biosensor readouts for heavy metals is out now in Nature Chemical Biology!
See paper here: Engineered bacterial swarm patterns as spatial records of environmental inputsPress release for bacterial patterns as visible biosensors that record environmental signals
Candice Gurbatri’s preprint is online! Colorectal cancer detection and treatment with engineered probiotics
Our collaboration on how bacteria was used to release chemokines to treat tumors is out on Science Advances!
See paper here: Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunityOur collaboration on creating genetic systems that could function as a diagnostic tool for measuring SCFAs and as delivery vehicles for biotherapeutic molecules is out on Microbiology Spectrum!
See paper here: Engineered bacteria for short-chain-fatty-acid-repressed expression of biotherapeutic molecules
2022
Our review as part of Science magazine’s special issue on cell engineering: Engineering bacteria as interactive cancer therapies
Our work on bacteria spheroid coculture is out now in Nature Protocols!
See paper here: A rapid screening platform to coculture bacteria within tumor spheroidsBarnard feature on our undergraduate student Stefani Shoreibah’s work: Cancer Researcher/Artist Stefani Alexis Shoreibah ’21
Cancer Research Institute article: Engineering Bacteria to Improve Cancer Immunotherapy with CRI Lloyd J. Old STAR Tal Danino features our lab’s research
Anjali Doshi’s preprint is online! Engineered bacterial swarm patterns as spatial records of environmental inputs
Nature Biomedical Engineering News & Views: Bacterial couriers as cancer vaccines
Anjali Doshi and Marian Shaw’s preprint is online! A deep learning pipeline for segmentation of Proteus mirabilis colony patterns.
2021
Nature Chemical Biology News & Views: CAR-T cells SEAK help from enzymes.
Our collaboration on how cancer-associated fibroblasts play an important role in colorectal cancer is out today in Gastroenterology!
See paper here: The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis. GastroenterologyTetsu Harimoto and Jaeseung Hahn’s preprint is online! A programmable probiotic encapsulation system enhances therapeutic delivery in vivo (bioRxiv)
Our work on engineered biosensor for bacterial targeting in vivo is out now in Nature Biomedical Engineering!
See paper here: Enhancing the tropism of bacteria via genetically programmed biosensorsOur work on studying viral replication at the sing-cell level is out now in Cell Systems!
See paper here: Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion
2020
Our work on engineering bacteria for production of volatile methyl salicylate is now out on ACS Synthetic Biology!
See paper here: Engineered Bacterial Production of Volatile Methyl SalicylateOur work on designer probiotics for cancer immunotherapy is out in Science Translational Medicine!
See paper here: Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Press release on designer probiotics for cancer immunotherapy
Nature Medicine Research Highlights: Delivering immunotherapy with bacteria
Columbia News: Designer probiotic treatment for cancer immunotherapy
C&EN: Bacteria producing checkpoint inhibitors shrink tumors in mice
GEN: Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice
BBC Science Focus: Seek and destroy: beneficial bacteria programmed to fight cancer
National Cancer Institute article Off Target: Investigating the Abscopal Effect as a Treatment for Cancer features our lab’s research
2019
Watch our TED-Ed lesson on Hacking bacteria to fight disease
Read about Sreyan Chowdhury’s work in Nature Medicine’s end of year feature
Tiffany Chien and Tetsu Harimoto’s preprint is online! Multiplexed biosensors for precision bacteria tropism in vivo (bioRxiv)
Our review paper (Harimoto et al.) is published in Emerging Topics in Life Sciences
Our work on programmable bacteria for immunotherapeutic delivery is out in Nature Medicine!
See paper here: Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Press release on programmable bacteria for immunotherapeutic delivery
Nature Medicine News and Views: Programmable bacteria as cancer therapy
New York Times: New Weapons Against Cancer: Millions of Bacteria Programmed to Kill
Columbia News: Bacteria Engineered as Trojan Horse for Cancer Immunotherapy
Recommendations on F1000; Research Highlight in Nature Reviews Drug Discovery
Our collaboration with Barnes Lab on plasmid stabilizing mechanisms is out in iScience!
See paper here: Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coli
Our work on engineered bacteria in 3-D spheroids is out in PNAS!
See paper here: Rapid screening of engineered microbial therapies in a 3-D multicellular model
Press release on engineered microbial therapies in a 3-D multicellular model
Columbia News: Bacterial Therapy in a Dish
Our lab hosted Columbia’s first Biohackathon with Lars Dietrich (Biology) and David Benjamin (GSAPP)
Danino lab receives NSF CAREER Award
Danino lab awarded Emerson Collective Cancer Research Fund with Dr. Nick Arpaia
2018
Danino Lab collaborates with Liberty Science Center for Microbes Rule! exhibit
Tetsu Harimoto’s preprint is online! Rapid screening of engineered microbial therapies in a 3-D multicellular model (bioRxiv)
New York Times article Scientists Are Retooling Bacteria to Cure Disease features Tal and our lab’s research
Our collaborative works with the Barnes group at UCL are online:
Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity. (Cell Systems)
Two new plasmid post-segregational killing mechanisms for the implementation of synthetic gene networks in E. coli (bioRxiv)Dr. Tal Danino awarded ALCF-VAPF Young Innovators Team Awards for Lung Cancer Research with Dr. Nick Arpaia.
Postdoc Zakary Singer is Awarded NIH Grant F32
PhD students Candice Gurbatri and Anjali Doshi are awarded NSF GRFPs
Our lab is awarded Vagelos Precision Medicine Award with Dr. Nick Arpaia
2017
Our collaboration on intratumoral bacteria in pancreatic patients is out today in Science!
See paper here: Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.Press release on intratumor bacteria
The Atlantic: How Bacteria Could Protect Tumors From Anticancer Drugs
New Scientist: Tumour bacteria sabotage chemotherapy by destroying cancer drugs
Danino Lab awarded DoD $2.5M Era of Hope Scholar Award.
Current Opinions in Systems Biology publication (Chien et al.) is published.
TED Blog article The Most Beautiful Bacteria You'll Ever See.
2016
3DP+ publication (Moon et al.) and cover art published today! Congrats to all.
Our cover art featured on Columbia Engineering magazine
Nature publication on Synchronized cycles of bacterial lysis for in vivo delivery
Press release on synchronized bacteria drug-delivery
Columbia News: Professor Tal Danino Programs Bacteria to Destroy Cancer Cells
Nature: Synthetic biology: Bacteria synchronized for drug delivery
Cell Systems: Synthetic Bacterial Lysis for Cancer Therapy
MIT Press: Cancer-fighting bacteria
The Scientist: Arming Synthetic Bacteria Against Cancer
ScienceBlog: Synthetic Biology Used to Limit Bacterial Growth and Coordinate Drug Release
Wall Street Journal article on Vik Muniz's experimental school in Rio de Janeiro's Vidigal favela, Escola Vidigal. Our lab is working on educational programs using science, art, & technology to visualize the path a bacteria takes through the human body.
The Creators Project article on the exhibit Microuniverses at Eyebeam.
Our image highlighted on TheScientist's Image of the Day.
2015
Tal selected as one of Cool Hunting's 25 List. The CH25 is a showcase of creators and innovators from a broad range of disciplines who are currently working to drive the world forward.
Science Translational Medicine article on programmable probiotics for detection of cancer in urine
Press on Programmable Probiotics for cancer detection in the urine.
MIT Press: Diagnosing cancer with help from bacteria
Popular Science: Mutant bacteria will test you for disease and color your pee accordingly
Los Angeles Times: Talented bacteria detect cancer, diabetes
The Scientist: Next Generation: Souped-up Probiotics Pinpoint Cancer
Science: Engineered bacteria detect cancer and diabetes in urine
U.S. News & World Report: Helpful bacteria may help detect cancers that have spread to liver
Science Daily: Diagnosing cancer with luminescent bacteria: Engineered probiotics detect tumors in liver
BBC News: Bacteria sensors ‘detect diabetes and cancer’
Mentioned in Wired UK: 21 inspiring TED Fellows changing the world in 2015
TED Blog interview about our work and art.
Talk from TED2015 on "Programming bacteria to detect cancer (and maybe treat it)" is live on TED.com website today!
New article we collaborated on in Cell: Hepatitis C Virus RNA Functionally Sequesters miR-122
BBC: TED 2015 - Bacteria programmed to find tumours
Fast Company article on how programmable probiotics could soon let you know if you have cancer -- from the color of your pee!
Our work and commentary featured in the article, A Beautiful Wallpaper made with Smallpox Vaccine on WIRED.com
Our Fashion deScience collaboration mentioned in the article, The Devil Wears Pulsars in The Atlantic.
Another article on the Gates Foundation work in Boston Magazine.
A New York Times article on a great vaccine campaign from the Gates Foundation that we are featured in.